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 1 
Abstract 1 
 2 
Objective – To describe the clinical presentation, advanced imaging findings, and short and 3 
long term outcomes in dogs with intracranial empyema.  4 
Design – Retrospective case series 5 
Animals – Client owned dogs diagnosed with intracranial empyema 6 
Methods – Medical records from 2 referral hospitals were searched for dogs diagnosed with 7 
intracranial empyema. To be included in this study, dogs had to fulfill 1 or more of the 8 
following 3 inclusion criteria: a magnetic resonance imaging (MRI) scan with space occupying 9 
accumulation of extra‐axial material suggestive of empyema, a cerebrospinal fluid analysis 10 
suggestive of empyema, or direct visualization of purulent material during intracranial surgery. 11 
Results – Nine dogs with intracranial empyema were included, with a median age of 3.5 years 12 
(range 4 months-12.5 years). All presented as emergencies with 7 of the 9 dogs showing 13 
neurological abnormalities and 2 of the 9 with retro-bulbar swelling and exophthalmos. Six 14 
had surgical intervention, one was medically managed and the remaining two dogs were 15 
euthanized. Typical MRI findings included extra-axial, T1-weighted hypo to isointense, T2-16 
weighted hyperintense material compared to grey matter with varying degrees of contrast 17 
enhancement, with 6/8 showing evidence of contiguous infection from adjacent structures on 18 
MRI. Seven had one or more samples sent for culture and sensitivity with Enterococcus 19 
(surgical swab), Streptococcus pneumonia (from CSF) and coagulase positive Staphylococcus 20 
(ear swab) being cultured. The median antimicrobial course length was 6 weeks (range 2 – 28 21 
weeks). All dogs for which treatment was attempted survived to discharge, with a median 22 
hospitalization time of 7 days (range 4-10 days). Four of the seven are still alive at the time of 23 
writing (1 lost to follow up; 2 euthanized for other reasons) with all four considered 24 
neurologically normal with a successful long term outcome.  25 
 2 
Conclusions – Although intracranial empyema in dogs is a rare condition, excellent outcomes 26 
are possible in those cases treated appropriately. 27 
 3 
Introduction 28 
 29 
Intracranial empyema is a neurological emergency that once diagnosed, requires rapid 30 
and aggressive intervention that comprises both surgical and medical management. 31 
Mechanisms of infection are thought to include hematogenous spread from other foci within 32 
the body (e.g septic emboli), contiguous infection from adjacent structures (inner ears, 33 
cribriform plate, sinuses and eyes), direct access (trauma, bite wound, iatrogenic 34 
(surgery/cerebrospinal fluid (CSF) acquisition)) and migration of foreign bodies or aberrant 35 
parasites1-5. Infectious agents reported to be implicated in intracranial empyema include 36 
Staphylococcus spp., Streptococcus spp., Nocardia spp., Pasteurella spp., Actinomyces spp., 37 
Fusobacterium spp., Bacteroides spp. And Peptostreptococcus spp and occasionally fungal 38 
organisms5-7. 39 
Intracranial empyema is a relatively rare condition, which is reflected in the limited 40 
number of reports currently in the veterinary literature, particularly concerning dogs. Although 41 
uncommon in people, intracranial empyema has been extensively described in the human 42 
medical literature with decompressive surgery and culture considered to be the gold standard 43 
in management of human cases8-10. Little is known about the clinical presentation, imaging 44 
findings and outcome in dogs, potentially stalling diagnosis and subsequent treatment. To the 45 
authors’ knowledge, this is the first case series specifically evaluating the clinical features of 46 
intracranial empyema in dogs from multiple sources with the aim of describing its presentation, 47 
diagnostic imaging findings, treatment options and outcome. The aim is that by detailing such 48 
cases, we will attain a better understanding of the condition to allow owners to make a more 49 
informed decision regarding treatment. 50 
Materials and Methods 51 
 4 
 52 
Medical records from two referral centers between December 2008 and November 53 
2015 were searched to identify dogs that had been diagnosed with intracranial empyema. To 54 
be included in this study, dogs had to fulfill 1 or more of the following 3 inclusion criteria: a 55 
magnetic resonance imaging (MRI) scan with space occupying accumulation of extra‐axial 56 
material suggestive of empyema, a CSF analysis suggestive of empyema, or direct visualization 57 
of purulent material during intracranial surgery. Dogs that received surgical, medical, or both 58 
forms of treatment were included. Dogs were excluded from the series if medical records or 59 
imaging studies were incomplete or unavailable for review or if a final diagnosis of intracranial 60 
empyema could not be reached. This study was approved by the clinical ethical research 61 
committee board of the Royal Veterinary College RVC (reference number 2016 1526B) 62 
 63 
Information retrieved from the medical records included signalment, history, general 64 
physical and neurological examination findings, concurrent medical conditions, imaging 65 
findings, CSF cytology, culture and sensitivity results, treatment administered, surgical 66 
procedure if performed, presence of complications and short term outcome. 67 
 68 
All dogs were anesthetized and MRI scans were performed using a 1.5 or 0.4 Tesla 69 
scanner (Intera; Philips Medical Systems or Aperto, Hitachi Medical Corporation, Tokyo, 70 
Japan) or a CT scan using a 16 multi detector row unit CT scanner (Mx8000 IDT, Philips, Best, 71 
the Netherlands). Anesthetic protocols differed among dogs, premedication with methadone 72 
(0.2mg/kg IV), anesthetic induction with propofol (1mg/kg IV and then to effect) and 73 
maintenance of anesthesia with sevoflurance in oxygen was a frequently used protocol. All 74 
imaging series were available for review and comprised a minimum of T2-weighted, T1-75 
weighted and T2-weighted FLAIR sequences and included transverse, sagittal and dorsal 76 
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images, with T1-weighted images acquired before and after IV administration of gadolinium 77 
contrast agent (0.1 mmol/kg gadoterate meglumine, Dotarem ®; Guerbet, Milton Keynes, UK 78 
or 0.05 mmol/kg gadobenate dimeglumine, Multihance ®; Bracco, Milan, Italy). All imaging 79 
studies were reviewed for diagnostic accuracy by two board certified neurologists (SDD and 80 
IP) and a residency trained radiologist (SG) and only those cases with imaging features 81 
consistent with intracranial empyema were included in the study. These features include the 82 
presence of extra-axial material that is T1 weighted hypointense, T2 weighted hyperintense 83 
with peripheral or heterogenous contrast enhancement together with contrast enhancing 84 
meninges.  85 
 86 
CSF analysis was performed in selected cases (cisternal: total nucleated cell count 87 
((TNCC) <5 cells/µl)), total protein (TP) 25mg/dl)). Owners were informed of the findings and 88 
the treatment options were discussed with a board-certified veterinary neurologist or resident 89 
in a veterinary neurology training program. The final decision for medical or surgical treatment 90 
or euthanasia was made by the owner of each dog.  91 
 92 
Short-term outcome was defined as the period immediately following intervention up 93 
to the point of discharge and re-examination visits 4-6 weeks following treatment. Long-term 94 
outcome was obtained initially via telephone conversation with the referring veterinary 95 
surgeons. For dogs that were deceased, date and cause of death, as well as the last documented 96 
neurological status were recorded. Conforming to hospital ethics and welfare committee 97 
guidelines, only owners of dogs that were confirmed alive at the time of data collection were 98 
subsequently contacted. Owners were posted a letter with study details and a standardized 99 
questionnaire that had been reviewed and approved by the hospital ethics and welfare 100 
committee. Telephone interviews were conducted using the questionnaire, which included 101 
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questions covering the patients’ quality of life, neurological status, any long term medication 102 
and overall response to treatment. 103 
 104 
Results  105 
 106 
Nine dogs with a median age of 3.5 years (range 4 months-12.5 years) were included 107 
in this study (Table 1). Four dogs were male (one neutered) and five were female (two neutered). 108 
Breeds included Labrador Retriever (n = 1), King Charles Spaniel (n = 2), Cocker Spaniel (n 109 
= 1), Jack Russell Terrier (n = 1), Golden Retriever (n = 1), Hungarian Viszla (n = 1) Bassett 110 
Hound (n = 1) and a cross breed (n = 1). All dogs presented with an acute onset of progressive 111 
clinical signs and seven of the nine dogs had been placed on antibiotics prior to referral. Despite 112 
seven of these dogs receiving empirical antibiosis prior to presentation, no improvement was 113 
seen and their signs continued to progress. Duration of clinical signs varied from 1 to 4 days 114 
(median 3 days, mean 2.8 days). General physical examination revealed abnormalities in six 115 
dogs, including a heart murmur (n=3 dogs), chronic dermatitis/otitis externa (n=1), 116 
submandibular lymphomegaly (n=2), pain on opening of the jaw (n=2) and pyrexia (n=2 dogs).  117 
Indications of a potential primary source of infection were observed in six dogs. This included 118 
unilateral exophthalmos (n=3), craniofacial wounds (n=2) and otitis externa (n=1). 119 
 120 
Neurological examination revealed abnormalities in seven dogs, which included 121 
obtundation (n=5), postural reaction deficits (n=5), and cranial nerve deficits (n=5). Two of 122 
these dogs had experienced generalized tonic-clonic seizures prior to presentation. The two 123 
dogs without neurological deficits presented for further evaluation of unilateral exophthalmos. 124 
 125 
Six dogs had complete blood cell counts performed on admission, two of which were 126 
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unremarkable, with abnormalities including neutrophilia (n=2), lymphocytosis (n=1) and mild 127 
anemia (n=1). Biochemistry was also performed in six dogs with no abnormalities identified. 128 
Three dogs did not have complete blood cell counts or biochemistry performed at the time of 129 
admission but did have venous blood gas analysis and blood smear evaluation performed with 130 
no abnormalities detected. Urinalysis was performed in one dog which revealed moderate 131 
hematuria and proteinuria with a negative bacterial culture. Thoracic radiography (n=1) and 132 
abdominal ultrasonography (n=1) were unremarkable. Echocardiography was performed in the 133 
three dogs with heart murmurs, two of which were consistent with mitral valve disease and the 134 
third with a congenital defect affecting the aortic valve. One dog had an ocular ultrasound 135 
which revealed signs consistent with retrobulbar cellulitis. Two dogs had ophthalmic 136 
examinations by board certified ophthalmologists with one having age related nuclear sclerosis 137 
and cataracts and the other having conjunctival hyperemia, exophthalmos and third eyelid 138 
protrusion.  139 
 140 
All dogs had advanced imaging performed within 24 hours of presentation. Eight of the 141 
nine cases underwent MRI of the head with one case undergoing cranial CT. MRI revealed the 142 
presence of extra-axial material, which appeared T1weighted hypointense (n=6) or isointense 143 
(n=2) and T2 weighted hyperintense (n=8) to grey matter. On fluid attenuation inversion 144 
recovery images (FLAIR) the material had a heterogenous intensity (n=5) or was hyperintense 145 
(n=3) to grey matter. In two cases the material was extensive and compressing half of the 146 
cerebral cortex, with the remaining cases having material compressing one or more of the 147 
frontal lobes (n=2), the parietal lobe (n=1), the olfactory lobe (n=2), the cerebellum (n=2), the 148 
brainstem (n=1), the thalamus (n=1) and the temporal lobe (n=1), with the location often 149 
dictated by the source of infection. In seven of the eight cases the material appeared subdural 150 
in nature as it was crescent in shape and crossing suture lines. Perilesional edema was identified 151 
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in four of the eight cases. A degree of osteomyelitis was identified in five cases, affecting the 152 
frontal bone (n=3), the temporomandibular joint and calvarium (n=1) and the sphenoid bone 153 
(n=1). The material was contrast enhancing with peripheral (rim) enhancement (n=5) or 154 
heterogenous contrast enhancement (n=3). Meningeal enhancement was also evident in all 155 
cases and was predominantly dural in nature (n=8) with some dogs also having a degree of 156 
leptomeningeal enhancement as well (n=5).   Five of the eight cases had evidence of mass 157 
effect in the form of midline shift (n=5), ventricular compression (n= 3), foramen magnum 158 
herniation (n=2) and caudal transtentorial herniation (n=1). (Figures 1 and 2). The 159 
neuroanatomical localization following examination of forebrain (n=5) and central vestibular 160 
syndrome (n=2) was consistent with the lesion location on MRI in all cases. In the two dogs 161 
that had a history of generalized seizure activity, the empyema identified on MRI was affecting 162 
the right side of the cerebrum in one dog and the left thalamus and left temporal lobe in the 163 
other dog.  164 
 165 
CSF analysis was performed in two cases and the first revealed a pleocytosis (35% 166 
neutrophils; 40% monocytes/macrophages) with a TNCC of 260 cells/µl and total protein of 167 
59 mg/dl. The cytology revealed occasional degenerate neutrophils, rarely containing very 168 
small coccoid structures and thin rod like structures. The structures identified were not 169 
convincing enough to definitively confirm intracellular bacteria and unfortunately this sample 170 
was not sent for culture. The second case did not have sufficient sample for a total nucleated 171 
cell count but did have a protein of 475 mg/dl and cytology consistent with a neutrophilic 172 
pleocytosis. The neutrophils varied from mature to variably karyolitic, frequently having 173 
phagocytosed the bacteria which were mature small diplococcoid in nature. Culture of the latter 174 
revealed a moderate growth of Streptococcus pneumonia.  175 
 176 
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Following the suspected diagnosis of intracranial empyema, six of the cases had 177 
surgical intervention either in the form of a single craniectomy (n=4), multiple small 178 
craniectomies (n=1) or a total ear canal ablation and lateral bulla osteotomy (n=1). Of those 179 
dogs that had intracranial surgery, two had a transfrontal approach and three a rostrotentorial 180 
approach, with the mean surgery time being 136 minutes (range:110-185mins). A durotomy 181 
was performed, which was followed by extensive lavage with saline before closure. A 182 
cranioplasty was not performed in any of the cases (Figure 3). Purulent fluid was seen and 183 
sampled for bacterial culture in all surgically treated cases. Of the 5 dogs that underwent a 184 
craniectomy, a neurological decline was not seen in any following the surgery; 2 remained 185 
neurologically normal, 2 remained neurologically static, and 1 experienced an immediate 186 
neurological improvement following surgery. 187 
 188 
Of the remaining three cases, one was medically managed in the form of intravenous 189 
antibiosis administration and supportive care. Enrofloxacin and amoxicillin clavulanic acid 190 
were administered intravenously for 10 days before changing to oral enrofloxacin and 191 
amoxicillin clavulanic acid. This medically managed case had not received any antibiotics prior 192 
to referral and the decision to medically manage this case was owner driven, as they did not 193 
want any further invasive diagnostic or treatment modalities. The remaining 2 were euthanized 194 
immediately after diagnosis without treatment attempted. Of those dogs that underwent 195 
treatment (either medical or surgical), 4 of 7 had treatment initiated within 24 hours of 196 
presentation, 2 of 7 had treatment initiated within 36 hours of presentation, and 1 of 7 had 197 
treatment initiated within 48 hours of presentation. 198 
 199 
 Seven cases had one or more samples sent off for culture and sensitivity from surgery 200 
(n=5), fine needle aspirate (FNA) of an intra-oral lesion (n=1), CSF (n=1) or an ear swab (n=1). 201 
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From these samples, five returned with no bacterial isolates, one returned with Enterococcus 202 
(surgical swab), one with Streptococcus pneumonia (from CSF) and one with coagulase 203 
positive Staphylococcus (ear swab). Seven of the nine dogs received antibiotics prior to referral 204 
which included the two dogs with positive cultures. Four of the five dogs that had surgical 205 
samples taken for culture were already on antibiotics, and the one that hadn’t received any 206 
antibiotics returned with no bacterial isolates.  207 
 208 
All cases received antibiotics with seven cases being on at least two different types of 209 
antibiotics (Table 1). Antibiotics were initially given intravenously and subsequently changed 210 
to oral administration. Antibiotics were administered intravenously for between 2 and 10 days 211 
(mean 5 days, median 4 days) before being changed to oral administration. The median 212 
antimicrobial course length was 6 weeks (range 2 – 28 weeks). Some dogs received a short 213 
course (48 hours) of intravenous corticosteroids (n=2 (0.1-0.3mg/kg IV; Colvason; Norbrook 214 
0.2%w/v)). Administration of intravenous mannitol was considered on an individual basis with 215 
bolus administration in case of suspected increased intracranial pressure. A total of four dogs 216 
were administered mannitol (n=4 (0.3-0.5g/kg IV)), with three receiving a single dose during 217 
the surgical procedure and the fourth dog receiving a dose during surgery and 48hours and 72 218 
hours post-operatively. The latter was administered the extra doses of mannitol due to concerns 219 
that the dog was showing clinical signs suggestive of increased intracranial pressure. All four 220 
dogs that received mannitol had evidence of increased intracranial pressure on their MRI scans.    221 
 222 
Seven out of the nine dogs survived to discharge, with the median time hospitalized 223 
being 7 days (range 4-10 days), with the one case medically managed being hospitalized for 224 
10 days. One dog developed a corneal ulcer whilst hospitalized, which was medically managed 225 
with topical medication to which it responded to well. A neurological improvement was seen 226 
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within 24 hours (n=5), 48 hours (n=1) and within 72 hours (n=1) following intervention. At 227 
the time of discharge, three of the dogs were neurologically normal and the other four, whilst 228 
still showing neurological deficits (cranial nerve deficits n=3; postural deficits n=2; head tilt 229 
n=1), had all shown a neurological improvement. The two that did not survive to discharge 230 
were euthanized at the time of diagnosis without treatment attempted. One dog was euthanized 231 
under general anesthetic following the MRI scan with no reason given as to why treatment 232 
wasn’t pursued, despite treatment being offered. The second dog was euthanized as the owners 233 
did not want to proceed because of an uncertain prognosis together with a lack of guarantee 234 
the dog would regain a good quality of life. Whilst the two euthanized dogs were neurologically 235 
abnormal at the time of presentation (similar to the other dogs in this series), nothing could be 236 
identified on their MRI scans or clinical notes that would have given a suggestion that these 237 
two dogs were precluded from having a similar outcome as the other dogs in this series if 238 
treatment was attempted.   239 
 240 
Given the external signs evident on clinical examination, together with the advanced 241 
imaging findings, the routes of infection were suspected to be intra-oral (n=2), retro-bulbar 242 
(n=3), external trauma (n=2) and otogenic (n=2). For the two cases suspected to be intra-oral 243 
in nature, lesions were identified in the mouth when both patients were induced for anesthesia. 244 
Subsequent MRI revealed one to have an abscess involving the temporomandibular joint 245 
extending intra-cranially through the skull and the other revealed signs consistent of contiguous 246 
infection extending to the sphenoid bone and in towards the left temporal lobe at the level of 247 
the thalamus. One of the otogenic cases had underwent a total ear canal ablation and lateral 248 
bulla osteotomy 6 months prior to presentation on the same side as the empyema. 249 
 250 
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Of the seven cases that survived to discharge, we attained long term follow up for six 251 
(Table 1). Four of the six were still alive at the time of writing with all four being neurologically 252 
normal and free of clinical signs according to the owners and the referring veterinary surgeons. 253 
None of the dogs were on any long term treatment nor experienced recurrence of clinical signs. 254 
The two remaining dogs were euthanized for unrelated reasons. One was euthanized 3 years 255 
following surgery for gastrointestinal disease and the other was euthanized 17 months 256 
following diagnosis due to congestive heart failure. At the time of death, both cases were 257 
neurologically normal other than one dog retaining a mild head tilt according to the referring 258 
veterinary surgeons.  259 
 260 
Discussion 261 
 262 
Intracranial empyema is a neurological emergency that once diagnosed, requires rapid 263 
and aggressive intervention. For an owner, making decisions regarding treatment can be 264 
challenging given the expensive and invasive nature of surgical intervention and the 265 
uncertainty of the prognosis. To the authors knowledge, this is the first case series in the 266 
veterinary literature evaluating the clinical presentation, diagnostic findings, treatment and 267 
outcome of dogs diagnosed with intracranial empyema.  268 
 269 
This case series highlights the differing presentations and underlying causes of 270 
intracranial empyema in dogs. The presumed sources of infection in this case series comprised 271 
otogenic, traumatic, retrobulbar and intra-oral extensions of infection. Interestingly, whilst 272 
sinusitis, otitis and skull trauma are amongst the most common sources of infection for human 273 
subdural empyema, the most common current etiology is subsequent to a neurosurgical 274 
procedure such as surgical evacuation of a subdural haemorrhage8,11 It is possible with the 275 
 13 
continued advancement of veterinary neurology coupled with increasingly performed 276 
intracranial surgery, there is the potential to see intracranial empyema more commonly as a 277 
complication following veterinary neurosurgical procedures. 278 
 279 
Despite these variations within a particular condition, a consistent finding was the acute 280 
and progressive nature of the clinical signs. A previous study investigating otogenic 281 
intracranial infection categorized the onset of neurologic dysfunction into acute (1-48 hours), 282 
subacute (3-7 days) or chronic (> 7days), with the majority of the patients in that series having 283 
a chronic onset2. Elsewhere in the veterinary literature, the onset of neurological signs in cases 284 
with intracranial empyema have varied with some being acute, subacute or chronic in nature1, 285 
25. In our series, the duration of clinical signs varied from 1 to 4 days (median 3 days, mean 2.8 286 
days). If we were to categorize similarly to the previous study, then 4/9 would be classed as 287 
acute and 5/9 would be subacute. It is possible that certain origins of empyema are associated 288 
with an acute onset of neurological signs. This hypothesis however needs further investigation 289 
in future studies.  Another striking finding of this case series was despite the severity of the 290 
presenting clinical signs, the majority of those cases in which treatment was attempted resulted 291 
in a good outcome. Only one of the cases presented in this series was medically managed, the 292 
majority being surgically treated. Although being presented with a dog with intracranial 293 
empyema can be overwhelming and stressful, our findings suggest that rapid and aggressive 294 
intervention can result in a successful outcome. 295 
 296 
Although intracranial empyema is a manifestation of an infectious disease, general 297 
physical examination findings and ancillary diagnostics, such as a complete blood count, 298 
biochemistry, urinalysis, echocardiography, and abdominal and thoracic imaging did not reveal 299 
clear indications of a more generalized infectious process. For all dogs in which treatment was 300 
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attempted, one or more samples were submitted for bacterial culture and sensitivity testing. 301 
However only three of a total of eight samples returned culture positive, one each from a 302 
surgical swab, ear swab and CSF sample. Previous literature in the subject has suggested that 303 
culturing from CSF is not normally rewarding and CSF analysis itself is often not specific for 304 
bacterial abscessation7,12,13. Whilst the ear swab and CSF positive cultures were from the same 305 
dog, it was considered unlikely the ear swab isolate was the cause of the intracranial empyema. 306 
The fact that different isolates were cultured should not be considered surprising given that in 307 
dogs with otitis media, cultured samples from the horizontal ear canal and the middle ear have 308 
been reported to demonstrate different results in 89.5% of ears24. Culture directly from the 309 
surgical site was positive in just one of the five cases that had sampling from that site in this 310 
case series, and this particular case was already receiving antibiotics. A possible explanation 311 
for this could be due to the fact that the majority (7/9) of cases were placed on antibiotics prior 312 
to referral, which has previously been discussed in the literature6,13. Blood culture was not 313 
attempted in any of these dogs but could potentially be considered as an additional ancillary 314 
diagnostic in dogs with intracranial empyema given its use in other neurological disorders such 315 
as discospondylitis and spinal epidural empyema22,23. 316 
 317 
Appropriate surgical aftercare is a key component in order to successfully treat dogs 318 
with intracranial empyema. Most surgically treated dogs underwent a craniectomy, after which 319 
not only the basic principles of post-operative aftercare were adhered to but specific 320 
recommendations of care following intra-cranial surgery were considered. The use of 321 
corticosteroids in patients with intracranial empyema remains a contentious issue, 322 
demonstrated by the fact that only two of the nine dogs in this case series were administered 323 
corticosteroids. Corticosteroids have been administered to the majority of reported cases in the 324 
veterinary literature2,25,26. It is thought antibacterials administered to these patients induce 325 
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cellular destruction of bacteria and subsequent lipopolysaccharide liberation, leading to the 326 
initiation of a cascade of inflammatory events14,15. However, It is suggested that 327 
dexamethasone early in the treatment of bacterial meningitis, decreases the inflammatory 328 
response associated with the release of bacterial cell material16,17. In the human literature, the 329 
results are inconclusive, with previous reports supporting the use of short term anti-330 
inflammatory doses of corticosteroids in people with bacterial meningitis, as they are beneficial 331 
in lowering intracranial pressure and reducing CNS inflammation27. However a recent 332 
systematic meta-analysis examining the use of adjunctive dexamethasone in patients with 333 
bacterial meningitis failed to suggest a clear benefit28. 334 
 335 
It remains unclear how long dogs with intracranial empyema should be kept on 336 
antibiotics for. In the absence of positive bacterial culture and sensitivity results, a broad 337 
spectrum, bactericidal antimicrobial with the ability to cross the blood-brain barrier and reach 338 
adequate concentrations in the central nervous system should be considered the ideal choice12,13. 339 
Whilst the majority of patients in this case series were placed on two different antibiotics, 340 
amoxicillin clavulanic acid was the most commonly used. Whilst this is a broad spectrum 341 
antimicrobial, it does not cross the blood-brain barrier effectively. It is however not completely 342 
clear how important the ability to cross the blood-brain barrier truly is in patients with 343 
intracranial empyema. It can indeed be assumed that animals with such severe brain pathology 344 
do no longer have an intact blood-brain barrier, allowing penetration of antimicrobials that 345 
might otherwise be restricted10,18. A further consideration is the fact that the majority of the 346 
empyema in this case series was epidural or subdural in nature and hence outside the blood-347 
brain barrier. Enhancement following intravenous contrast administration was a consistent 348 
finding on MRI, further illustrating the questionable importance of blood-brain barrier 349 
penetration for antibiotics administered in patients with intracranial empyema.  Whilst there is 350 
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no consensus on the length of antimicrobial therapy for these patients, demonstrated here by 351 
the wide range of 2-28 weeks, it is generally accepted that antibiosis should be initially 352 
administered intravenously followed by an oral course long term19.   353 
 354 
The median age of dogs in this case series was 2 years, with four of the nine dogs being 355 
less than 12 months old. This is consistent with the human literature where the majority of 356 
patients with intracranial empyema are between 10-20 years old20,21. Whether these dogs have 357 
a more immature immune system or are more prone to traumatic episodes is unclear. Although 358 
this finding could indeed suggest a predisposition for younger animals to suffer from 359 
intracranial empyema, a larger sample size would be needed to evaluate this hypothesis.  360 
 361 
Whilst the MRI characteristics of intracranial empyema have previously been 362 
described1,2,5, this is the first case series focusing on intracranial empyema in dogs from 363 
multiple different sources of infection. Generally, the empyema was subdural (occasionally 364 
epidural) in nature, T1 weighted hypointense and T2 weighted hyperintense with peripheral or 365 
heterogenous contrast enhancement. Evidence of concurrent osteomyelitis and a degree of 366 
mass effect was identified in individual cases. These MRI characteristics when considered 367 
together with the history and clinical signs of the patient can be considered suggestive of 368 
intracranial empyema. In differentiating subdural empyema from a subdural hematoma, you 369 
might expect the latter to potentially be more isointense to brain parenchyma on T2 weighted 370 
images, lack a contrast enhancing rim and one might also expect the presence of signal void on 371 
T2* weighted images26.  372 
 373 
This study is obviously limited by its retrospective nature, which restricted standardized 374 
patient assessment and treatment. Standardization of patient care was further limited by the 375 
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heterogeneous nature of included cases. Despite including animals over a 7-year period from 376 
two busy referral centers, only 9 dogs could be included. Although this could be considered a 377 
limitation of the study, this finding is most likely a reflection of the rare nature of intracranial 378 
empyema in dogs. Despite the small number and heterogeneous character of included cases, 379 
several clinically important conclusions can be drawn from this study. Intracranial empyema 380 
in dogs is rare, but can present as a neurological emergency that requires rapid and aggressive 381 
treatment. Affected dogs can present neurologically normal and the majority of patients do not 382 
demonstrate evidence of systemic disease on general physical examination or ancillary 383 
diagnostics. Treatment of intracranial empyema seems to be associated with excellent 384 
outcomes and a rapid recovery. Further studies are needed to evaluate the most appropriate 385 
type of surgical aftercare, type and duration of antibiotic treatment.  386 
 387 
 388 
  389 
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Figure legends 456 
Figure 1: MRI of a 7 year male entire Jack Russell Terrier with subdural empyema. The images 457 
show a T2weighted (A), T1weighted (B), T2weighted FLAIR (C) and T1weighted after IV 458 
administration of gadolinium based contrast (D) transverse images of the brain at the level of 459 
the thalamus. There is accumulation of extra-axial, crescent shaped, T2weighted hyperintense, 460 
T1weighted hypointense material compressing the left cerebral hemisphere (asterisk). The 461 
material does not suppress on FLAIR (C) and following gadolinium administration there is a 462 
peripheral enhancement of the material (D) and both dural and leptomeningeal diffuse contrast 463 
enhancement. There is a degree of midline shift and compression of the lateral ventricle (white 464 
arrow).  465 
 466 
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Figure 2: Transverse T2weighted (A), transverse T1weighted after IV administration of 467 
gadolinium based contrast (B), dorsal T1weighted (C) and dorsal T1weighted after IV 468 
administration of gadolinium based contrast (d) MR images of a 6-month old crossbreed with 469 
intracranial empyema. Accumulation of extra-axial, lentiform, T2weighted hyperintense, 470 
T1weighted hypointense material adjacent to the frontal and parietal lobes on the right hand 471 
side (white arrow). Following gadolinium there is a peripheral enhancement of the material 472 
(B and C) and there is a degree of midline shift to the left. There is also a degree of 473 
osteomyelitis (A and B: asterisk) with T2 weighted hyperintense thickening of the periorbital 474 
and retrobulbar tissues of the right eye. The right frontal sinus also contains hyperintense 475 
material together with a degree of mucosal thickening.  476 
 477 
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Figure 3: Rostrotentorial craniectomy in a 6 month old female entire Labrador retriever with 479 
subdural empyema secondary to a retrobulbar infection. A) Following the craniectomy, the 480 
intact dura is visible but appears discolored (white arrow). B) The dura has been incised and 481 
the empyema is visible in situ (asterisk). C) Following an intraoperative swab for culture and 482 
sensitivity, the empyema is removed and flushed with copious amounts of saline, with normal 483 
brain parenchyma now visible (white arrow).  484 
 485 
 486 
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